NATERA, INC. Proceeds from Divestiture of Businesses
NATERA, INC. (NTRA) reported Proceeds from Divestiture of Businesses of $9.68 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromDivestitureOfBusinesses · last filed 2022-02-25
- NATERA, INC. proceeds from divestiture of businesses for the quarter ending 2019-12-31 was $0.00.
- NATERA, INC. proceeds from divestiture of businesses for the quarter ending 2019-09-30 was $9.68M.
- NATERA, INC. proceeds from divestiture of businesses for fiscal 2019 was $9.68M.
| Period end | Proceeds from Divestiture of Businesses 3 month | Proceeds from Divestiture of Businesses 6 month | Proceeds from Divestiture of Businesses 9 month | Proceeds from Divestiture of Businesses 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $9.68M derived: sum of 2 quarters · filed 2022-02-25 | $9.68M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $9.68M 10-Q · filed 2020-11-06 | $9.68M 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |